Back to mobile site

More on QNRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/7/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Quoin Pharmaceuticals Ltd (NQ:QNRX)
Delayed: 4.74 +1.49 (45.85%)
Prev. Close $3.25  
Open$4.27 
52 Wk High$ 
52 Wk Low$ 
Day High$4.74 
Day Low$4.03 
P/E N/A  
EPS$ 
Volume4,570,275 

Friends, Peers and Foes (?): 2EB0 (more...)

Jun 23, 2026 04:16 PM Form 8-K Quoin Pharmaceuticals, For: Jun 23
Jun 23, 2026 08:31 AM FDA conditionally approves QYLEKI as brand name for Quoin drug
Jun 23, 2026 08:30 AM Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
Jun 18, 2026 08:31 AM Quoin Pharma forms Japan subsidiary to advance QRX003 commercialization
Jun 18, 2026 08:30 AM Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003
Jun 16, 2026 08:31 AM Quoin Pharmaceuticals reports 4 of 6 patients improved in NS compassionate use trial
Jun 16, 2026 08:30 AM Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
Jun 15, 2026 06:07 AM ThinkEquity Starts Quoin Pharmaceuticals (QNRX) at Buy
Jun 4, 2026 04:04 PM Form 8-K Quoin Pharmaceuticals, For: Jun 04
Jun 4, 2026 08:31 AM Japan's health ministry grants orphan drug status to Quoin's QRX003
View All Articles

Entities mentioned with QNRX

View All Entities